MENU
LFMD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

LFMD stock forecast, quote, news & analysis

LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services... Show more

LFMD
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for LFMD with price predictions
Jun 22, 2026

LFMD sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for LFMD moved above the 200-day moving average on June 16, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LFMD advanced for three days, in of 293 cases, the price rose further within the following month. The odds of a continued upward trend are .

LFMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LFMD as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for LFMD turned negative on June 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

LFMD moved below its 50-day moving average on June 22, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LFMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (13.870) is normal, around the industry mean (7.367). LFMD has a moderately low P/E Ratio (0.000) as compared to the industry average of (49.962). LFMD's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.152). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (1.030) is also within normal values, averaging (5.631).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LFMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LFMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 99, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Teladoc Health (NYSE:TDOC).

Industry description

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

Market Cap

The average market capitalization across the Services to the Health Industry Industry is 2.04B. The market cap for tickers in the group ranges from 708 to 24.88B. VEEV holds the highest valuation in this group at 24.88B. The lowest valued company is OTRKQ at 708.

High and low price notable news

The average weekly price growth across all stocks in the Services to the Health Industry Industry was -2%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was -14%. SLP experienced the highest price growth at 11%, while MGRX experienced the biggest fall at -19%.

Volume

The average weekly volume growth across all stocks in the Services to the Health Industry Industry was 12%. For the same stocks of the Industry, the average monthly volume growth was 45% and the average quarterly volume growth was 187%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 77
Price Growth Rating: 58
SMR Rating: 88
Profit Risk Rating: 99
Seasonality Score: 26 (-100 ... +100)
View a ticker or compare two or three
LFMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Profile
Details
Industry
N/A
Address
236 Fifth Avenue
Phone
+1 866 351-5907
Employees
389
Web
https://www.lifemd.com
LFMD sees its 50-day moving average cross bullishly above its 200-day moving average